High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome.
about
Secondary use of clinical data: the Vanderbilt approachCNR1 genotype influences HDL-cholesterol response to change in dietary fat intakeCYP4A11 variant is associated with high-density lipoprotein cholesterol in women.'Triglyceride effect' on the dynamics of plasma lipoproteins and its possible link to atherogenesis.Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives.Biobanks and Their Clinical Application and Informatics Challenges.
P2860
High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
High-density lipoprotein (HDL) ...... edictors of treatment outcome.
@ast
High-density lipoprotein (HDL) ...... edictors of treatment outcome.
@en
type
label
High-density lipoprotein (HDL) ...... edictors of treatment outcome.
@ast
High-density lipoprotein (HDL) ...... edictors of treatment outcome.
@en
prefLabel
High-density lipoprotein (HDL) ...... edictors of treatment outcome.
@ast
High-density lipoprotein (HDL) ...... edictors of treatment outcome.
@en
P2860
P356
P1476
High-density lipoprotein (HDL) ...... edictors of treatment outcome.
@en
P2093
P2860
P2888
P304
P356
10.1038/TPJ.2010.86
P577
2010-12-14T00:00:00Z